| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 150,701 | 134,046 | 138,263 | 149,779 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 134,046 | 138,263 | 149,779 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 161,783 | 104,570 | 99,238 | 134,357 | | Non Recurring | (1,339) | (8,128) | 8,128 |
-
| | Others | 29,015 | 28,795 | 29,406 | 32,122 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (38,758) | 8,809 | 1,491 | (16,700) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (38,758) | 8,809 | 1,491 | (16,700) | | Interest Expense | (20,169) | 20,169 |
-
| 9,670 | | Income Before Tax | (18,589) | (11,360) | 1,491 | (26,370) | | Income Tax Expense | (8,433) | (6,026) | (1,779) | (11,528) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,156) | (5,334) | 3,270 | (14,842) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,156) | (5,334) | 3,270 | (14,842) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,156) | ($5,334) | $3,270 | ($14,842) |
|
0.11% Nasdaq 
0.01%
Income Statement
